About
Basic Data Updated:
28 days agoFormulations are manufactured and marketed by East India Pharmaceutical Works Limited (EIPWL). Two of its key products, Enteroquinol and Tonoferon, have active pharmaceutical ingredients (API) produced by the company. Other formulations utilize APIs from external manufacturers. EIPWL operates two manufacturing units in West Bengal, with a formulation plant situated in Sarsuna and an API plant located in Durgapur. The company's capabilities include the production of tablets, dry syrup, liquid orals, ointments, and various packaging materials. These formulations primarily fall under therapeutic segments such as antiprotozoal, haematinic, analgesic & antipyretic, eye care products, probiotic, antibacterial, anti-infective, and multi-vitamins/enzymes. EIPWL's key formulations are manufactured in-house, while the remaining products are outsourced to contract manufacturers through the loan-licensing model. In addition to its pharmaceutical offerings, EIPWL also manufactures and markets a range of ayurvedic medicines. With a commitment to quality and innovation, the company continues to expand its product portfolio and reach new markets.
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Website12224421
- Telephone12224421
- Email Address12224421
- Social Media12224421
| CIN/LLPIN/FCRN | U24231WB1936PLC008598 |
| Company No. | 008598 |
| Company Classification | Public Limited Indian Non-Government Company |
| Incorporation Date | 27 Apr 1936 |
| Date of AGM | 22 Sep 2023 |
| Date of Balance Sheet | 31 Mar 2023 |
| Listing Status | Unlisted |
| ROC Code | Roc Kolkata |
Products or Services related to East India Pharmaceutical Works Limited
Psoriasis Ointment
Dietary Supplements
Body Care Products
Digestive Drugs
Financials of East India Pharmaceutical Works Limited
East India Pharmaceutical Works Limited, for the financial year ended 2021, experienced modest growth in revenue, with a 8.92% increase. The company also saw a substantial improvement in profitability, with a 56.89% increase in profit. The company's net worth moved up by a moderate rise of 5.43%.
Corporate Structure
Unlock access to East India Pharmaceutical Works's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
People in East India Pharmaceutical Works Limited
Unlock and access historical data on people associated with East India Pharmaceutical Works, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Executive Team (4)
Debarshi Duttagupta
Managing DirectorAppointment Date: 30-Jun-2010
Status: Current
SM
Satarupa Mukherjee Managing DirectorAppointment Date: 07-May-2019
Status: Current
SR
Somnath Ray CFOAppointment Date: 01-Jan-2023
Status: Current
JS
Jayeeta Sarkar Company SecretaryAppointment Date: 01-Nov-2019
Status: Current
Board Members(9)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Oct 2023 | ₹2.80 M | Open |
Others Creation Date: 16 May 2023 | ₹1.10 M | Open |
Others Creation Date: 29 Nov 2022 | ₹3.33 M | Open |
Deals i
Gain comprehensive insights into the Deals and Valuation data of East India Pharmaceutical Works, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped East India Pharmaceutical Works's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alert
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Related Corporates (Common Directorship)
Industrial And Prudential Investment Company Limited
Active
110 years 8 months Probir Roy is a mutual person
Recent activity within the organization
Charges
A charge with Others of Rs. 0.28 cr registered on 10 Oct 2023 with Charge ID 100790937 was modified on 20 Mar 2024.
20 Mar 2024Charges
A charge with Others of Rs. 0.11 cr registered on 16 May 2023 with Charge ID 100728199 was modified on 20 Mar 2024.
20 Mar 2024Charges
A charge registered on 16 Dec 2020 via Charge ID 100403314 with Hdfc Bank Limited was fully satisfied on 02 Jan 2024.
02 Jan 2024Charges
A charge registered on 24 Sep 2020 via Charge ID 100403089 with Hdfc Bank Limited was fully satisfied on 20 Oct 2023.
20 Oct 2023Charges
A charge registered on 19 Feb 2020 via Charge ID 100329871 with Hdfc Bank Limited was fully satisfied on 16 Oct 2023.
16 Oct 2023
Frequently asked questions
What is the Incorporation or founding date of East India Pharmaceutical Works Limited?
